Skip to content

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

The story archive

Every discovery.
A little clearer.

Browse the collection, follow a topic, or find the story that sparked your curiosity.

500 published stories

253
Oncology

A European scoring system successfully predicts bladder cancer risks

Bladder cancer that has not spread deep into the muscle wall is common but unpredictable. Doctors call this non-muscle-invasive bladder cancer. Even within specific types of this disease, such as high-grade tumors that look aggressive under a microscope, some patients heal well while others see their cancer return or worsen. To help predict who faces the biggest risks, medical experts in Europe created a tool in 2021 to sort patients into different risk categories. Recently, researchers put that tool to the test to see if it actually works in real clinical settings. The research team looked back at the medical records of 316 patients. They used the European classification system to group these individuals as having either an intermediate risk or a high risk based on factors like age, the number of tumors, and tumor size. The tool proved to be highly effective. Patients placed in the high-risk group were much more likely to experience a cancer relapse or see their disease progress compared to those in the intermediate-risk group. For example, over 97 percent of intermediate-risk patients went three years without their cancer worsening, compared to about 91 percent of high-risk patients. While the tool was excellent at predicting if the cancer would return or grow, it did not predict overall life expectancy. Patients in both risk groups had similar chances of staying alive, avoiding bladder removal surgery, and surviving the cancer itself. The researchers note a few limitations to their findings, pointing out that the study looked back at past data rather than tracking new patients, relied on a moderate group of 316 people, and followed their health for an average of just 36 months.

PubMed · 2 min read
254
Neurotech

Brain cells divide the labor of learning from motor mistakes

When you learn a new physical skill, like playing a chord on a guitar, your brain is hard at work taking in sensory information and controlling your movements. Scientists have long studied the frontal cortex, a brain region crucial for this type of motor control. Recently, researchers looked closer to see if different parts of a single brain cell handle this information differently. Specifically, they compared the main cell body, known as the soma, to its tree-like receiving branches, called apical tuft dendrites. By observing brain activity with advanced imaging while subjects learned a new physical task, the researchers found a fascinating division of labor. The cell bodies kept track of both the sensory cues in the environment and the actual physical movements being made. The branching dendrites, however, were mostly focused on sensory cues. Interestingly, when a movement mistake occurred, these branches showed unique bursts of activity specifically tied to the corrective actions taken to fix the error. As the new motor skill was mastered over time, the cell bodies and their branches adapted in fundamentally different ways. This process is known as functional plasticity, meaning the different parts of the cell independently altered how sensitive they were to incoming signals. This shows that a single brain cell is not just a simple relay switch, but a highly complex processor.

bioRxiv · 2 min read
255
Neurotech

How rhythmic movements help the brain overcome attention blind spots

Have you ever missed a word in a conversation because you were momentarily distracted by another sound? Scientists call this brief gap in perception an "attentional blink." It happens when your brain is so busy processing one piece of sensory information that it temporarily ignores the next. But researchers have discovered an unexpected way to bridge these brief gaps in attention: moving your body to a rhythm. In a recent study, scientists tested whether rhythmic physical movements could help the brain process sounds. They asked participants to listen for specific audio cues during a task designed to trigger these attentional blind spots. The researchers found that perfectly timed finger tapping helped people detect sounds they would have otherwise completely missed. Interestingly, this hack only worked when the brain was struggling to keep up. If the brain already had plenty of attention to spare, the finger tapping actually became a distraction and impaired their listening performance. To prove that the brain's movement centers were directly driving this effect, the team used a non-invasive technique called transcranial alternating current stimulation, or tACS. By applying a gentle, rhythmic electrical current to the sensorimotor area of the brain, they could artificially recreate the benefits of physical movement. When the timing of the electrical peak matched the sound, the participants avoided the attentional blink entirely. Conversely, stimulating the opposite side of the brain at the lowest point of the electrical wave made the blind spots worse. This proves that our motor system is not just for moving muscles, but actively shapes how we pay attention to our environment.

bioRxiv · 2 min read
256
Neurotech

Why older brains remember the gist but forget the details

Have you ever noticed that as people get older, they tend to remember the broad strokes of an event but forget the specific details? Neuroscientists may have found a biological explanation for this shift by looking at how the brain processes time. The research focuses on the hippocampus, a brain region that acts as our main memory center. In younger people, this area is organized by a gradient of brain activity speeds. One end handles slow, big-picture information, while the other processes fast, fine-grained details. To see how this changes with age, researchers scanned the brains of younger and older adults while they watched movies. Younger adults showed the expected organization of brain activity speeds from the front to the back of the hippocampus. However, older adults showed a completely reversed pattern. Matching this flipped brain activity, the older participants had a harder time recalling specific details from the movies, instead remembering mostly the general gist of the story. The researchers also found that in younger brains, having slower brain activity in certain areas directly predicted a less detailed, more gist-like memory. Curiously, this direct link between brain activity speed and memory detail vanished entirely in the older group. While these findings offer a fascinating glimpse into the aging mind, the researchers caution that some results regarding the brain's outer layers were based on exploratory analysis. Additionally, the exact number of participants is not specified in this early report, meaning more research will be needed to confirm these patterns.

bioRxiv · 2 min read
257
Neurotech

Mimicking evolution helps artificial intelligence learn much faster

When humans or animals learn a new skill, they do not start from a blank slate. Biological brains come equipped with built-in structures shaped by millions of years of evolution. This innate wiring allows nature to perform "few-shot learning", meaning organisms can pick up new tasks after just a few attempts. In contrast, standard artificial neural networks (computer systems designed to process information like a brain) usually start completely random and blank. Because they lack this evolutionary head start, these artificial networks require massive amounts of training data to learn comparable skills. To see if computers could benefit from nature's approach, researchers developed a novel algorithm that combines the rules of natural selection with standard machine learning techniques. By simulating evolutionary conditioning, they hoped to build artificial networks that learn more like living brains. Interestingly, the researchers found that this evolutionary simulation by itself did not instantly create a highly capable system. On its own, the conditionally evolved network performed about the same as a basic, untrained computer model. However, a major difference emerged once the researchers actually started teaching the networks. The artificial models shaped by simulated evolution showed unique, hidden learning dynamics that allowed them to rapidly fine-tune their skills. Instead of blindly guessing through trial and error, the artificially evolved networks used their built-in foundational traits to accelerate the learning process and quickly reach optimal performance.

bioRxiv · 2 min read
258
General Biotech

Fast-moving Ebola outbreak triggers global health emergency

The World Health Organization has officially declared the ongoing Ebola outbreak an international public health emergency. The virus, which first emerged in the Democratic Republic of the Congo, has now sparked travel-related cases in major urban centers. These include Kinshasa, the capital of the Congo, and Kampala, the capital of neighboring Uganda. What stands out about this announcement is how quickly global leaders took action. African health officials confirmed the outbreak on a Friday, and the international emergency declaration followed just one day later on Saturday. This highly unusual speed signals a deep concern among experts that health authorities might already be trailing behind the rapid spread of the disease. Because this is a very early situational update, public health officials are operating with limited information. Current reports do not yet include specific data regarding total case counts, exact death rates, or detailed tracking of how the disease is moving through communities.

STAT News · 1 min read
259
Oncology

A New Blueprint for Thriving After Breast Cancer

For people recovering from breast cancer, what happens after treatment is just as critical as the therapy itself. Research shows that staying physically active and eating a plant-forward diet are linked to a lower risk of death. However, managing body weight remains a major hurdle. Having an elevated body mass index, or BMI, at the time of diagnosis, or gaining weight after treatment ends, is tied to worse cancer outcomes and a higher overall risk of dying. While doctors routinely recommend lifestyle changes to combat this, the results are often limited. Everyday barriers like a lack of time and insufficient training make these habits hard to maintain. Consequently, standard lifestyle adjustments usually result in only modest weight loss and have mixed effects on long-term survival. Because of this, scientists are looking at alternative medical tools, including GLP-1 receptor agonists, a popular class of weight management medications. Early studies looking back at past patient records suggest these drugs are a promising option that might improve both overall survival and heart health for breast cancer survivors. Physical health is only part of the equation, as the psychological toll of the disease lingers. Up to 59 percent of breast cancer survivors grapple with an intense fear that their cancer will return. Crucially, this anxiety does not simply fade away as time passes. It requires targeted psychological interventions, proving that mental health care is an essential piece of the recovery puzzle.

PubMed · 2 min read
260
Digital Health

Finding the Sweet Spot: How Texting Boosts Cancer Screening

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Medical guidelines recommend that screening begins at age 45, but getting people to actually complete these tests remains a major challenge, especially in medically underserved communities. To find a better way to reach patients, researchers tested whether simple text messages could nudge adults to get screened. The study tracked more than 4,800 patients across two large community health networks in Texas and California that serve vulnerable populations. Participants were divided into four groups. One group received no text messages, while others received either a single reminder, a three-week series of messages, or a six-week series. Researchers then tracked whether patients completed one of three common screening methods within 90 days. These methods included a traditional colonoscopy or at-home stool tests, specifically the fecal immunochemical test and Cologuard. The results showed that a moderate approach worked best. Patients receiving the three-week text series were significantly more likely to complete their overall screening than those who received no texts, and even a single message provided a slight boost. Interestingly, sending too many texts seemed to dilute the benefit. The six-week messaging group did not show a significant overall advantage over the group receiving no messages. Researchers suspect this is due to message fatigue, where patients simply tune out frequent notifications. However, texting was uniquely effective for patients using the Cologuard test, making them up to seven times more likely to complete it. While these findings are promising, the researchers caution that the study was limited to two specific health center networks, meaning the exact results might not perfectly generalize to every hospital or community.

PubMed · 2 min read
261
Digital Health

Why Online Cancer Support Groups Work for Some, But Not All

For people navigating a cancer diagnosis, the internet often feels like a lifeline. Online support groups offer a convenient space to find information, share experiences, and connect with others who truly understand. A comprehensive new review of 168 studies looked at exactly how these digital communities impact cancer patients and survivors. The researchers found that when these groups work well, they provide a powerful mix of emotional comfort, practical advice, and a sense of purpose from helping others. This combined support can significantly lower feelings of isolation and boost a patient's overall mental well-being. However, logging on is not a guaranteed cure for loneliness. The research team discovered that online support groups are not universally beneficial. A community's success heavily depends on how well it matches an individual's specific needs, attitudes, and coping style. Technology features, like whether users can stay anonymous and protect their privacy, play a massive role in whether someone feels safe. Group dynamics, such as active moderation and empathetic interactions, are equally crucial. If a group is a bad fit for a patient, participating can actually increase their distress rather than relieve it. To make these platforms more effective, the researchers emphasize that digital communities must be carefully designed and consistently monitored. Developers and moderators need to focus on building trust, ensuring privacy, and actively managing conversations so that users feel understood, accepted, and valued.

PubMed · 2 min read
262
Immunology

Pregnancy Does Not Worsen Myasthenia Gravis, But Postpartum Risks Remain

Women with myasthenia gravis, a chronic condition that causes muscle weakness, often face uncertainty when deciding to start a family. Doctors have long wondered if the physical toll of pregnancy might trigger dangerous flare-ups of the disease. However, a recent nationwide study offers reassuring news. Researchers found that being pregnant does not actually increase a woman's risk of being hospitalized for myasthenia gravis symptoms compared to the year before she conceived. In fact, the data suggests that women tend to get pregnant during periods when their disease is already relatively stable. While the nine months of pregnancy appear largely safe, the landscape shifts after delivery. The study revealed that the postpartum period, especially the first three months after giving birth, carries a significantly higher risk for prolonged symptom flare-ups that require a hospital stay. This pattern is also reflected in how patients manage their treatments. During pregnancy, many women safely reduced or completely paused their immune-suppressing medications. Once the baby was born, however, doctors frequently had to restart or increase these prescriptions to bring the mother's symptoms back under control. Although these findings provide valuable guidance, the researchers note a few important limitations. The study tracked 112 women across 176 pregnancies, which is a relatively small group. Because the scientists relied on national medical registries, they only captured severe flare-ups that led to hospitalization or clear medication changes. Milder symptom worsening that patients managed at home likely went unrecorded. Moving forward, larger prospective international studies will be needed to fill in these missing details.

PubMed · 2 min read
263
Oncology

Scientists Target New Enzyme to Halt Drug-Resistant Melanoma

Melanoma, a dangerous form of skin cancer, is often driven by a specific genetic mutation called BRAFV600E. While treatments exist to target this mutation, cancer cells frequently develop resistance, allowing tumors to grow unchecked. Now, scientists have discovered a potential new way to stop these stubborn cancer cells in their tracks by targeting a specific enzyme called ICMT. To understand how this works, picture a cancer cell as a busy factory. For the factory to keep producing tumor cells, certain worker proteins must physically attach themselves to the outer walls, or cell membranes. The enzyme ICMT acts like a supervisor that gives these proteins the final clearance to attach to the membrane. Researchers found that blocking ICMT, either through genetic tweaking or a drug called UCM-1336, stops a critical protein named INPP5E from reaching the cell membrane. Without INPP5E in its proper place, the melanoma cells lose their ability to multiply and invade surrounding tissue. To prove that INPP5E was the key player, the research team artificially forced the protein back onto the cell membranes. When they did this, the cancer cells partially regained their ability to grow, confirming that displacing INPP5E is the secret to the treatment's success. Most importantly, turning off the ICMT enzyme successfully halted the growth of melanoma cells that had already become resistant to standard therapies.

PubMed · 2 min read
264
Diagnostics

Faster, Dye-Free MRI Accurately Detects Liver Cancer Spread

When colorectal cancer advances, it frequently spreads to the liver, creating secondary tumors that doctors call metastases. To find these liver tumors and plan life-saving treatments, physicians typically rely on a magnetic resonance imaging, or MRI, scan that uses an injected contrast dye. While highly effective, this standard approach has drawbacks. It is expensive, time-consuming, and unsafe for patients with kidney problems or severe allergies. To find a better option, researchers investigated a faster, dye-free alternative known as an abbreviated non-contrast MRI. In a recent study, the research team reviewed the past scans of 87 patients with colorectal cancer. They wanted to see if this shorter protocol could spot liver tumors just as accurately as the traditional method without requiring any contrast dye. The results were remarkably positive. The dye-free scans correctly detected the cancer up to 94.1 percent of the time and accurately ruled it out up to 96.2 percent of the time. To test how easy the images were to interpret, the researchers had both an expert radiologist and an in-training doctor review the scans. The trainee performed just as well as the veteran specialist, and both doctors consistently agreed on the diagnoses.

PubMed · 1 min read